Marco Ventimiglia

7PUBLICATIONS
16CO-AUTHORS
HydrometallurgyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 10, 2024
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).

Valeria Dipasquale, Salvatore Pellegrino, Marco Ventimiglia

|May 06, 2023
Ustekinumab is a promising option for the treatment of postoperative recurrence of Crohn's disease.

Fabio Salvatore Macaluso, Mauro Grova, Filippo Mocciaro

|Jul 02, 2021
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition.

Valeria Dipasquale, Marco Ventimiglia, Simone Maria Calogero Gramaglia

|Jun 21, 2021
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501.

Fabio Salvatore Macaluso, Maria Cappello, Anita Busacca

|Mar 18, 2021
Ustekinumab in Crohn's disease: Real-world outcomes from the Sicilian network for inflammatory bowel diseases.

Anna Viola, Marco Muscianisi, Fabio S Macaluso

Pageof 2